The company also will send letters to thousands of U.S. physicians notifying them of the risk similar to a letter it sent to Canadian physicians and pharmacists last October. The drug is approved only for schizophrenia, but is often used with elderly patients suffering from dementia and Alzheimer’s.
New drug warning
Johnson & Johnson said it plans to change the package insert of its second-best selling medicine, the antipsychotic drug Risperdal, to warn of a possible increased risk of stroke for elderly patients.
May 31, 2003
Recommended
Recommended
Recommended
Machinery Basics
Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—Packaging World editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
The AI revolution in packaging robotics is here
Robots that see variations, adjust grip pressure automatically, accept plain-English commands, and predict their own maintenance. Discover how AI is transforming packaging operations.
Read More
Downloads
